Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A multicenter prospective observational study of the conformity of temozolomide prescriptions in France.
Tilleul P, Brignone M, Hassani Y, Labrande C, Pedeboscq S, Gensollen S, Lahille B, Exinger D, Bertholle V, Billard M, Charlety D, Prebay D, Pinguet F, Taillibert S, Cartalat S, Chinot O, Borget I; Temozolomide Study Group of Société Française de Pharmacie Oncologique. Tilleul P, et al. Among authors: taillibert s. Pharmacoepidemiol Drug Saf. 2012 Aug;21(8):828-34. doi: 10.1002/pds.3233. Epub 2012 Mar 15. Pharmacoepidemiol Drug Saf. 2012. PMID: 22419509
[Prescription guidebook for temozolomide usage in brain tumors].
Tilleul P, Brignone M, Hassani Y, Taillandier L, Taillibert S, Cartalat-Carel S, Borget I, Chinot O. Tilleul P, et al. Among authors: taillibert s. Bull Cancer. 2009 May;96(5):579-89. doi: 10.1684/bdc.2009.0865. Bull Cancer. 2009. PMID: 19467988 Free article. Review. French.
Initial chemotherapy in gliomatosis cerebri.
Sanson M, Cartalat-Carel S, Taillibert S, Napolitano M, Djafari L, Cougnard J, Gervais H, Laigle F, Carpentier A, Mokhtari K, Taillandier L, Chinot O, Duffau H, Honnorat J, Hoang-Xuan K, Delattre JY; ANOCEF group. Sanson M, et al. Among authors: taillibert s. Neurology. 2004 Jul 27;63(2):270-5. doi: 10.1212/01.wnl.0000129985.39973.e4. Neurology. 2004. PMID: 15277619 Clinical Trial.
Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome.
Kaloshi G, Benouaich-Amiel A, Diakite F, Taillibert S, Lejeune J, Laigle-Donadey F, Renard MA, Iraqi W, Idbaih A, Paris S, Capelle L, Duffau H, Cornu P, Simon JM, Mokhtari K, Polivka M, Omuro A, Carpentier A, Sanson M, Delattre JY, Hoang-Xuan K. Kaloshi G, et al. Among authors: taillibert s. Neurology. 2007 May 22;68(21):1831-6. doi: 10.1212/01.wnl.0000262034.26310.a2. Neurology. 2007. PMID: 17515545
Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions.
Hoang-Xuan K, Capelle L, Kujas M, Taillibert S, Duffau H, Lejeune J, Polivka M, Crinière E, Marie Y, Mokhtari K, Carpentier AF, Laigle F, Simon JM, Cornu P, Broët P, Sanson M, Delattre JY. Hoang-Xuan K, et al. Among authors: taillibert s. J Clin Oncol. 2004 Aug 1;22(15):3133-8. doi: 10.1200/JCO.2004.10.169. J Clin Oncol. 2004. PMID: 15284265
Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial.
Stupp R, Taillibert S, Kanner AA, Kesari S, Steinberg DM, Toms SA, Taylor LP, Lieberman F, Silvani A, Fink KL, Barnett GH, Zhu JJ, Henson JW, Engelhard HH, Chen TC, Tran DD, Sroubek J, Tran ND, Hottinger AF, Landolfi J, Desai R, Caroli M, Kew Y, Honnorat J, Idbaih A, Kirson ED, Weinberg U, Palti Y, Hegi ME, Ram Z. Stupp R, et al. Among authors: taillibert s. JAMA. 2015 Dec 15;314(23):2535-43. doi: 10.1001/jama.2015.16669. JAMA. 2015. PMID: 26670971 Free article. Clinical Trial.
91 results